CGS-CIMB analyst Ngoh Yi Sin has maintained her “add” rating on IHH Healthcare, but with a lower target price of RM6.10 ($2.00) and lower earnings per share (EPS) forecast. 

Ngoh has cut her EPS forecast for FY20-22 by 7.3-25.2% to reflect lower patient footfall and the slower return of foreign patients. 

Ngoh noted that IHH Healthcare sank into core profit after tax and minority interests (PATMI) loss of RM84.2 million in 2Q20 compared to RM240.1 million core PATMI in 2Q19. 

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook